Comprehensive Analysis of the Credit Year and Administrative Framework of the Maryland Research and Development Tax Credit

The credit year represents the specific taxable period for which a qualified business entity calculates and claims the research and development tax credit against its Maryland state income tax liability. It serves as the chronological anchor for determining the four-year lookback period used to establish the Maryland base amount and defines the eligibility window for qualified research expenses.

The concept of the credit year is central to the administration, calculation, and reporting of the Maryland Research and Development (R&D) Tax Credit. Governed by Maryland Code, Tax-General § 10-721 and supplemented by the Code of Maryland Regulations (COMAR) 24.05.20, the credit year is not merely the year in which a tax return is filed, but the period during which the innovative activity occurred and the related expenses were paid or incurred.1 This distinction is critical because Maryland utilizes a growth-based incentive model, where the value of the credit is predicated on the taxpayer’s ability to exceed a historical baseline established relative to the credit year.3 A nuanced understanding of this term requires an examination of its statutory definitions, its role in complex incremental calculations, the procedural timelines for certification, and its interaction with federal standards under Internal Revenue Code (IRC) § 41.

The administrative architecture of the program is bifurcated between two primary state agencies: the Maryland Department of Commerce, which handles the application and certification process, and the Maryland Comptroller of the Treasury, which oversees the actual reporting and claiming of the credit on state tax returns.2 For practitioners and business owners, the credit year acts as the “year of record” for all qualifying activities, yet because of the unique certification lifecycle, the financial benefits of the credit often do not materialize until subsequent calendar years. This temporal gap necessitates meticulous record-keeping and a strategic approach to tax filing, particularly for small businesses that may be eligible for refundable credits.4

Statutory Foundations and Regulatory Definitions

The definition of a credit year within the Maryland R&D tax credit framework is explicitly provided in COMAR 24.05.20.01. It denotes the year for which the credit is being claimed.2 While this seems straightforward, the regulatory context expands this definition to integrate it with the “taxable year” of the business entity. For a qualified business entity, which can be a sole proprietorship, partnership, corporation, or other entity doing business in the state, the credit year must align with their federal accounting period.2 If a taxpayer operates on a fiscal year that differs from the calendar year, the credit year is the fiscal year that ends within the calendar year corresponding to the application cycle.7

The legal framework further distinguishes the credit year by its role in defining the “retention period” and the “revitalization area” eligibility in related tax programs. In the broader scope of Maryland’s economic development incentives, the credit year is often the starting point for a three-year period during which qualified positions must be maintained to avoid recapture of benefits.1 For the R&D credit specifically, the credit year is the “current year” in the incremental formula, as opposed to the “base years” that form the historical comparison.

Interaction with Federal Standards

Maryland’s R&D tax credit is heavily decoupled from certain federal provisions while remaining strictly tethered to others. The definition of “qualified research and development” and “qualified research expenses” (QREs) is adopted directly from IRC § 41(b) and (d).4 Consequently, any expense that qualifies for the federal R&D credit is generally eligible for the Maryland credit, provided the research activity was conducted physically within the state of Maryland.3

The state revenue office provides specific guidance on what constitutes “conducted in the State.” This determination involves assessing where the services were performed, the location of the employees or contractors performing the research, and where the supplies were consumed.4 The credit year serves as the window during which these geographic and functional tests must be satisfied. If a researcher spends 60% of their time in a Maryland lab and 40% in a Virginia lab during the credit year, only the 60% of their wages attributable to the Maryland work can be included in the state-level QRE calculation.4

The Multi-Step Certification and Claiming Lifecycle

The Maryland R&D credit is unique in that it is a “certified” credit rather than a “self-directed” credit. Taxpayers cannot simply calculate the credit and claim it on their initial return for the credit year. Instead, they must navigate a multi-year cycle involving application, state-level proration, and subsequent certification.4

As illustrated in the table above, the timeline for a single credit year spans parts of three calendar years. For a credit year ending December 31, 2023, the taxpayer must track expenses throughout 2023. They then have until November 15, 2024, to file an application that provides the total QREs for 2023 along with the historical data from the four prior years (2019–2022).4 The Department of Commerce processes these applications and, because the program has a statutory cap, calculates any necessary proration. The final certificate is issued by February 15, 2025.4

This delayed timeline is a critical administrative feature. The Department of Commerce requires this time to ensure the total amount of credits granted to all businesses does not exceed the legislative cap of $12 million.3 This cap is divided into two pools: $3.5 million set aside for small businesses and $8.5 million for all other business entities.4 Because the state must wait until all applications are received by the November 15 deadline, it cannot certify individual credits until the total “demand” is known.

Calculation Mechanics: The Incremental “Growth” Model

The Maryland R&D credit is primarily a growth-based incentive. Unlike states that offer a flat credit on all research spending, Maryland’s primary credit—the “Growth R&D Tax Credit”—is equal to 10% of the amount by which the QREs in the credit year exceed a calculated “Maryland Base Amount”.3 This design is intended to reward companies that are expanding their research footprint in the state rather than those with stagnant or declining research budgets.8

Determining the Maryland Base Amount

The base amount is a historical average that represents the level of R&D activity the company would likely have conducted without the incentive. Calculating this amount is the most complex part of the R&D application. It requires two key variables from the four taxable years immediately preceding the credit year: Maryland QREs and Maryland Gross Receipts.3

The calculation follows a specific sequence:

1. Calculate the Maryland Base Percentage: This is the aggregate Maryland QREs for the four preceding years divided by the aggregate Maryland Gross Receipts for those same four years.2
2. Calculate Average Annual Gross Receipts: The sum of Maryland Gross Receipts for the four preceding years divided by four.3
3. Establish the Base Amount: The Maryland Base Percentage multiplied by the Average Annual Gross Receipts.3

For new companies or those that have not been in business for four years prior to the credit year, the law allows the calculation to be based on the actual number of years the business existed.3 If a company is in its first year of incurring R&D expenses in Maryland, the base amount is effectively zero, allowing the company to claim 10% of its entire R&D budget as a growth credit.3

Adjustments for Short Taxable Years

The Maryland revenue office provides strict guidance on “partial year” or “short year” taxpayers. If a business entity has a taxable year of less than 12 months—often due to a change in fiscal year or a mid-year business launch—the base amount must be adjusted to ensure a fair comparison.2 The “Maryland Adjusted Base Amount” is calculated by multiplying the standard base amount by a fraction, where the numerator is the number of days in the short tax year and the denominator is 365.4 This adjustment prevents companies from receiving an outsized credit simply because their current year “growth” is being compared against a full 12-month historical average.7

Administrative Guidance for Small Businesses

Small businesses receive preferential treatment under the Maryland R&D tax credit program, reflecting the state’s goal of fostering a robust startup ecosystem, particularly in the life sciences and cybersecurity sectors.3 A small business is defined as a for-profit entity with “net book value assets” totaling less than $5 million at either the beginning or the end of the credit year.3

Net Book Value Asset Valuation

The term “net book value assets” is defined as the total net value of a business’s assets—including intangibles like patents or trademarks—minus accumulated depreciation and amortization.3 Crucially, this calculation does not subtract liabilities. A company with $6 million in assets and $4 million in debt would not qualify as a small business, as its total asset value exceeds the $5 million threshold regardless of its net equity.3

Small businesses must provide proof of this valuation by attaching a balance sheet or a federal tax return (such as Form 1040 or 1065) to their application.7 The Department of Commerce uses this data to verify that the entity qualifies for the $3.5 million small business set-aside and the benefit of refundability.4

Refundability and Cash Flow Implications

For large corporations, the R&D credit is non-refundable; it can only offset tax liability, and any excess must be carried forward for up to seven years.3 However, for certified small businesses, the credit is fully refundable for any certificates issued after December 15, 2012.4 This is a vital distinction for early-stage companies that are often pre-revenue or in a loss position and thus have no state income tax liability to offset.

If a small business is awarded a $100,000 credit but has $0 in Maryland tax liability, the Comptroller will issue a refund check for the full $100,000 once the certified credit is reported on a tax return.12 This effectively turns the R&D tax credit into a non-dilutive grant, providing critical working capital for Maryland’s innovation economy.3

Reporting Procedures for Different Taxpayer Types

The mechanism for claiming the credit after certification depends heavily on the legal structure of the business and its filing status with the Maryland Comptroller. Because the certification date (February 15) is often after the standard filing deadline for corporations (April 15), many taxpayers must amend their prior year returns to utilize the credit.4

Corporations (Form 500)

C-corporations are the most frequent claimants of the R&D tax credit. To report the credit, a corporation must file Maryland Form 500 and attach Form 500CR, which is the “Business Income Tax Credits” schedule.13 Part K of Form 500CR is dedicated specifically to R&D credits.13

The Comptroller mandates that any corporation claiming a business tax credit from Form 500CR must file their return electronically.13 If a corporation is unable to file electronically, it must submit Form 500CRW to request a waiver, citing reasonable cause or undue hardship.15 A copy of the Department of Commerce’s certification must be attached to the electronic return as a PDF.4

Pass-Through Entities (PTEs)

For S-corporations, partnerships, and LLCs, the entity itself does not pay the income tax; instead, the tax liability and the corresponding credits “pass through” to the individual members or partners.8

The administrative process for PTEs involves several layers of reporting:

1. Entity-Level Reporting: The PTE must file Maryland Form 510 (or Form 511 for electing PTEs) and complete the R&D section of Form 500CR.16
2. Schedule K-1 Distribution: The PTE provides each member with a Maryland Schedule K-1 (510/511), which explicitly states the member’s share of the R&D tax credit.16
3. Member-Level Claiming: Individual members then report their share of the credit on their own personal income tax returns (Form 502 or 505) by attaching Form 502CR.8

A critical timing rule for PTE members is that the credit is considered to be received by the member on the last day of the PTE’s taxable year.18 If a PTE has a fiscal year ending June 30, 2023, its members will claim the credit on their 2023 tax returns, even if the actual certification from the state does not arrive until early 2025.

Individual Taxpayers and Sole Proprietors

Individuals who conduct research through a sole proprietorship or receive credits via a PTE claim the credit using Form 502CR, “Income Tax Credits for Individuals”.8 Part D of Form 502CR is used for the R&D credit.8 Like corporations, individuals must attach the certification letter from the Department of Commerce to their return to substantiate the claim.4

Case Study: Detailed Credit Year Calculation

To clarify how these rules apply in practice, consider the following example of a Maryland manufacturing firm, “MD-Tech Fab,” during the 2023 credit year.

Financial Profile of MD-Tech Fab

The company has been in operation for over five years. It is not a small business, as its net book value assets are $12 million.

Step 1: Calculating the Fixed-Base Percentage

The fixed-base percentage is determined by the ratio of QREs to Gross Receipts over the lookback period (2019–2022).

$$Aggregate\ QREs = 2,200,000 + 2,000,000 + 1,800,000 + 1,600,000 = 7,600,000 \\ Aggregate\ Gross\ Receipts = 22,000,000 + 20,000,000 + 18,000,000 + 16,000,000 = 76,000,000 \\ Fixed\ Base\ Percentage = \frac{7,600,000}{76,000,000} = 10\%$$

Step 2: Calculating the Maryland Base Amount

First, determine the average annual gross receipts for the four preceding years:

$$Average\ Annual\ Gross\ Receipts = \frac{76,000,000}{4} = 19,000,000$$

Then, apply the fixed-base percentage to the average annual gross receipts:

$$Maryland\ Base\ Amount = 10\% \times 19,000,000 = 1,900,000$$

Step 3: Determining the Growth Credit

The growth credit is 10% of the amount by which the credit year QREs exceed the base amount.

$$Excess\ QREs = 3,000,000\ (2023\ QREs) – 1,900,000\ (Base\ Amount) = 1,100,000$$

$$Growth\ Credit = 10\% \times 1,100,000 = 110,000$$

MD-Tech Fab will apply for a $110,000 credit by November 15, 2024. If the state determines that total growth credit applications from non-small businesses are $17 million (exceeding the $8.5 million pool), the company’s credit will be prorated.4

$$Proration\ Factor = \frac{8,500,000}{17,000,000} = 0.50$$

$$Certified\ Credit = 110,000 \times 0.50 = 55,000$$

The company will receive a certificate for $55,000 in February 2025, which it can then use to offset its tax liability.4

Legislative Evolution: The 2021 Program Redesign

The Maryland R&D tax credit has undergone several legislative iterations since its reestablishment in 2005.22 The most significant recent change occurred in 2021 with the passage of Senate Bill 196.6

Repeal of the Basic Credit

Prior to 2021, Maryland offered two credits: the Basic R&D Credit (3% of expenses up to the base amount) and the Growth R&D Credit (10% of expenses over the base amount).2 The 2021 legislation repealed the 3% basic credit entirely.23 This change was driven by research from the Department of Legislative Services, which found that the basic credit often provided “windfall” benefits to large companies for R&D they would have conducted regardless of the incentive.6 By eliminating the basic credit, the legislature sought to concentrate state resources on incentivizing incremental growth rather than subsidizing the status quo.

Adjustments to Funding and Limits

Along with the repeal of the basic credit, the 2021 Act increased the annual aggregate funding for the growth credit from $6.5 million to $12 million.6 It also codified the $3.5 million set-aside for small businesses and established a maximum credit of $250,000 for any single applicant in a credit year.4 These measures were designed to ensure a more equitable distribution of the credit among a larger number of companies, particularly emerging technology firms.

Sunset and Extensions

The program is not permanent; it has a statutory “sunset” date. Currently, the R&D tax credit is authorized through June 30, 2027.3 The General Assembly periodically reviews the program to decide whether to extend or modify it based on economic impact evaluations.11

The 2024 Evaluation and Economic Impact Findings

As required by the Tax Expenditure Evaluation Act, the Department of Legislative Services (DLS) conducted a comprehensive reevaluation of the R&D tax credit in late 2024.11 The findings provide a critical look at how the program functions in the real-world Maryland economy.

Statistical Trends in Program Utilization

The 2024 evaluation noted that while Maryland remains one of the most R&D-intensive states in the nation, much of this activity is driven by federal agencies and contractors rather than private, state-incentivized research.11 DLS observed that between 2015 and 2021, business-funded R&D in Maryland grew by 61%, which lagged significantly behind the national growth rate of 84%.11

The report also found that the 2021 redesign successfully reduced the concentration of the credit among a few very large firms. However, DLS concluded that the $12 million annual cap is likely too small to meaningfully move the needle on statewide R&D investment levels.11

Administrative and Fiscal Insights

A nuanced finding of the 2024 report concerned the “unequal credit rates” resulting from administrative procedures. Because of the proration mechanism, two companies with identical R&D growth may receive different effective credit rates depending on which pool (small business vs. large business) they fall into and the total demand in that pool for the credit year.11

Furthermore, the report highlighted the “windfall” nature of the credit for companies that experience growth for reasons unrelated to the tax incentive, such as a major federal contract award or a merger. DLS recommended that the General Assembly consider whether a state match to federal Small Business Innovation Research (SBIR) grants might be a more effective use of the $12 million.11

Successor-in-Interest and Corporate Transactions

The handling of the credit year in the context of mergers and acquisitions is a significant source of complexity for both the Department of Commerce and the Comptroller. Maryland law follows a strict “successor-in-interest” rule to prevent companies from artificially creating “growth” by simply buying another company’s R&D department.

Mergers and Stock Purchases

When a company acquires another entity through a merger or a stock purchase, the surviving entity “inherits” the research history of the acquired company. For the credit year in which the transaction occurs, the parent company must combine its own QREs and gross receipts with those of the acquired entity.3 More importantly, the parent company must also include the acquired entity’s historical data for the four-year lookback period.4 Failure to include this historic data would result in a base amount that is too low, leading to an exaggerated growth credit.

Asset Purchases

The rules differ significantly for asset purchases. If a transaction involves only the purchase of assets rather than the entire legal entity, the R&D credits and the research history typically do not carry over to the buyer.4 The credits remain with the seller, as they are the legal entity that originally incurred the expenses during the credit year. This distinction is vital during due diligence for corporate acquisitions in Maryland’s high-tech sectors.

Compliance, Documentation, and Audit Readiness

The Maryland Comptroller’s Office and the Department of Commerce place a high premium on documentation. Because the R&D credit is essentially a “delayed” benefit—claimed via amendment long after the credit year has passed—the risk of documentation gaps is high.

Contemporaneous Record-Keeping

To satisfy the requirements of a state audit, which often aligns with the federal IRC § 41 standards, companies must maintain documentation that is contemporaneous with the credit year. This includes:

• Innovation Logs and Project Narratives: Documents describing the technical challenges, the alternatives evaluated, and the results of the experimentation.3
• Time Tracking Data: Detailed records identifying which employees worked on which R&D projects and for how many hours.3
• Supply Invoices: Evidence of the cost and location of supplies used in the research process.3
• Contractor Proof of Conduct: Statements or contracts proving that third-party research was conducted within Maryland borders.4

Good Standing Requirement

To be eligible for certification, a business must be in “Good Standing” with the State Department of Assessments and Taxation (SDAT) during the application year.7 This involves being current on all personal property tax filings and other state administrative requirements. The Department of Commerce will deny an application if the entity is listed as “not in good standing” on the Maryland Business Express website.12

Interplay with Other Maryland Incentive Programs

While the R&D tax credit is a standalone program, it often interacts with other Maryland incentives, and the definitions of “credit year” and “taxable year” remain consistent across these platforms.

Job Creation Tax Credit (JCTC)

The JCTC provides credits to businesses that create a minimum number of new, full-time positions in the state. Like the R&D credit, the JCTC utilizes a credit year to define when the positions were created and a subsequent retention period during which those jobs must be maintained.1 Companies conducting R&D often qualify for both, as research projects typically require the hiring of highly skilled, high-wage staff.

Biotechnology Investment Incentive Tax Credit (BIITC)

The BIITC is an investor-level credit designed to encourage investment in qualified Maryland biotechnology companies (QMBCs). The QMBC must be a company with fewer than 50 employees that is primarily engaged in research and development.24 Many companies that benefit from the R&D tax credit at the corporate level also serve as the vehicle for their investors to claim the BIITC.

The Income Tax Benefit Transfer Program (Proposed)

A noteworthy emerging trend in Maryland tax policy is the “Income Tax Benefit Transfer Program,” established by House Bill 35, effective July 1, 2025.26 This program will allow certain technology companies to “sell” or transfer their unused R&D tax credits and Net Operating Losses (NOLs) to other Maryland taxpayers.26 This could provide a secondary market for non-refundable R&D credits that would otherwise be stuck in a seven-year carryforward period for larger companies.

Challenges and Future Outlook

As Maryland approaches the 2027 sunset for the current R&D tax credit program, several challenges remain for both the state and the taxpayer community.

Managing the Statutory Cap

The $12 million cap remains a point of contention. The 2024 DLS evaluation noted that the program is routinely oversubscribed, particularly by non-small businesses.3 This oversubscription leads to heavy proration, which reduces the “certainty” of the incentive. A company that budgets for a $100,000 tax offset may only receive $50,000, which can complicate financial planning and lower the internal rate of return on Maryland-based research projects.

Federal Amortization and Section 174

The requirement under the federal TCJA to amortize R&D expenses rather than deducting them immediately has placed a financial burden on many innovators.29 While some states have “decoupled” from this federal rule to allow immediate expensing for state tax purposes, Maryland’s alignment with federal taxable income means that many Maryland firms are seeing an increase in their state-level tax liability even as they conduct eligible R&D.29 This makes the 10% growth credit even more critical as a tool to mitigate the increased tax burden.

The Shift Toward Impact-Based Evaluation

The 2024 DLS report suggests a shift in how Maryland evaluates its tax credits. There is an increasing focus on whether these incentives are actually changing corporate behavior or if they are simply rewarding activity that would have occurred regardless.11 For the R&D tax credit to remain a fixture of Maryland law, the business community will likely need to demonstrate a stronger causal link between the credit and new, high-value employment in the state.

Conclusion

The credit year is the vital pulse of the Maryland Research and Development Tax Credit, governing everything from the complex historical base amount calculation to the multi-year administrative lifecycle of certification. While the program offers a substantial 10% incentive on research growth, it requires a high degree of sophisticated tax management to navigate the state’s proration rules, the small business refundability criteria, and the successor-in-interest rules during corporate transactions. As the program evolves—moving from the two-credit “Basic and Growth” model to the current growth-centric $12 million program—it remains a cornerstone of Maryland’s strategy to attract and retain the nation’s leading innovative enterprises. Practitioners must ensure that their credit year tracking is both geographically precise and contemporaneously documented to maximize the benefits and withstand the scrutiny of both the Department of Commerce and the Comptroller of the Treasury.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/